INVIVO THERAPEUTICS HOLDINGS CORP. — Form D

INVIVO THERAPEUTICS HOLDINGS CORP. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-14. The offering totals $6.2M, of which $6.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Daniel Ann MarshakDirectorCambridge, MA
C. Ann MerrifieldDirectorWatertown, MA
Christina Ann MorrisonDirectorCambridge, MA
Richard Ann RobertsDirectorCambridge, MA
Robert Ann RosenthalDirectorCambridge, MA
Richard ToselliDirectorCambridge, MA
Richard ChristopherExecutive OfficerKelowna, A1
Heather Ann HamelExecutive OfficerCambridge, MA
Richard ToselliExecutive OfficerCambridge, MA
Adam K SternDirectorNew York, NY
Peter L CokerDirectorChapel Hill, NC
Peter L CokerExecutive OfficerChapel Hill, NC
Richard J RobertsDirectorCambridge, MA
George J NolenDirectorCambridge, MA
Frank M ReynoldsDirectorCambridge, MA
Frank M ReynoldsExecutive OfficerCambridge, MA
Christi M PedraDirectorCambridge, MA
Peter A ReichardDirectorChapel Hill, NC
Peter A ReichardExecutive OfficerChapel Hill, NC

Other filings by this issuer (3)

FiledFormOfferingSold
2020-04-28D$3.0M$3.0M
2010-11-09D/A$13.0M$10.5M
2010-10-06D$7.0M

More